Drugs, Diagnostic Agents and Disinfectants in Wastewater and Water - A Review

Klaus Kümmerer

Drugs, Diagnostic Agents and Disinfectants in Wastewater and Water - A Review

Publikation: Beiträge in Sammelwerken › Aufsätze in Konferenzbänden › Forschung › begutachtet

Standard

Drugs, Diagnostic Agents and Disinfectants in Wastewater and Water - A Review. / Kümmerer, Klaus.
Water Sanitation and Health (WHO Water Series) : resolving conflicts between drinking-water demands and pressures from society´s wastes ; proceedings of the international conference. Hrsg. / Ingrid Chorus; U. Ringelband; G. Schlag; O. Schmoll. Band 105 IWA Publishing, 2000. S. 59-71 (Schriftenreihe des Vereins für Wasser-, Boden- und Lufthygiene; Nr. 105).

Publikation: Beiträge in Sammelwerken › Aufsätze in Konferenzbänden › Forschung › begutachtet

Harvard

Kümmerer, K 2000, Drugs, Diagnostic Agents and Disinfectants in Wastewater and Water - A Review. in I Chorus, U Ringelband, G Schlag & O Schmoll (Hrsg.), Water Sanitation and Health (WHO Water Series) : resolving conflicts between drinking-water demands and pressures from society´s wastes ; proceedings of the international conference. Bd. 105, Schriftenreihe des Vereins für Wasser-, Boden- und Lufthygiene, Nr. 105, IWA Publishing, S. 59-71, International Conference on the Subject of "Water, Sanitation and Health" - 1998, Bad Elster, Deutschland, 24.11.98.

APA

Kümmerer, K. (2000). Drugs, Diagnostic Agents and Disinfectants in Wastewater and Water - A Review. In I. Chorus, U. Ringelband, G. Schlag, & O. Schmoll (Hrsg.), Water Sanitation and Health (WHO Water Series) : resolving conflicts between drinking-water demands and pressures from society´s wastes ; proceedings of the international conference (Band 105, S. 59-71). (Schriftenreihe des Vereins für Wasser-, Boden- und Lufthygiene; Nr. 105). IWA Publishing.

Vancouver

Kümmerer K. Drugs, Diagnostic Agents and Disinfectants in Wastewater and Water - A Review. in Chorus I, Ringelband U, Schlag G, Schmoll O, Hrsg., Water Sanitation and Health (WHO Water Series) : resolving conflicts between drinking-water demands and pressures from society´s wastes ; proceedings of the international conference. Band 105. IWA Publishing. 2000. S. 59-71. (Schriftenreihe des Vereins für Wasser-, Boden- und Lufthygiene; 105).

Bibtex

@inbook{3d5ba832f4e54d649ce040b2990e732d,

title = "Drugs, Diagnostic Agents and Disinfectants in Wastewater and Water - A Review",

abstract = "After administration pharmaceuticals are excreted by the patients into the aquatic environment via wastewater. Unused medications are sometimes disposed of in drains. The drugs may enter the aquatic environment and eventually reach drinking water, if they are not biodegraded or eliminated during sewage treatment. Additionally, antibiotics and disinfectants are assumed to disturb the wastewater treatment process and the microbial ecology in surface waters. Furthermore, resistant bacteria may be selected in the aeration tanks of sewage treatment plants by the antibiotic substances present. Since the 1980s, data on the occurrence of pharmaceuticals in natural surface waters and the effluents of sewage treatment plants have been reported. More recently, pharmaceuticals have been detected in ground and drinking water. However, only little is known about the risk imposed on humans by pharmaceuticals and their metabolites in surface and drinking water. An overview of input, occurrence, elimination (e.g. biodegradability) and possible effects of different pharmaceutical groups such as anti-tumour drugs, antibiotics and contrast media as well as AOX resulting from hospitals effluent input into sewage water and surface water is presented",

keywords = "Aeration, AGENTS, ANTIBIOTIC, Antibiotics, AOX, aquatic, aquatic environment, bacteria, BACTERIUM, biodegradability, contrast media, CONTRAST-MEDIA, diagnostic agent, disinfectant, disinfectants, drinking water, DRINKING-WATER, drug, DRUGS, ECOLOGY, effect, effects, effluent, EFFLUENTS, elimination, ENVIRONMENT, HEALTH, hospital, HOSPITALS, Human, HUMANS, MEDIA, Metabolite, METABOLITES, occurrence, PATIENT, pharmaceutical, pharmaceuticals, PLANT, PLANTS, REACh, RESISTANT BACTERIA, RESISTANT-BACTERIA, Review, risk, sewage, sewage treatment, sewage treatment plant, sewage treatment plants, SEWAGE WATER, SEWAGE-TREATMENT, SUBSTANCES, SURFACE, surface water, SURFACE WATERS, SURFACE-WATER, treatment, TREATMENT PLANTS, TREATMENT-PLANT, Waste, waste water, WASTE-WATER, wastewater, wastewater treatment, WATER, WATERS, WELL, Chemistry",

author = "Klaus K{\"u}mmerer",

year = "2000",

language = "English",

isbn = "3-932816-34-X",

volume = "105",

series = "Schriftenreihe des Vereins f{\"u}r Wasser-, Boden- und Lufthygiene",

publisher = "IWA Publishing",

number = "105",

pages = "59--71",

editor = "Ingrid Chorus and U. Ringelband and G. Schlag and O. Schmoll",

booktitle = "Water Sanitation and Health (WHO Water Series)",

address = "United Kingdom",

note = "International Conference on the Subject of {"}Water, Sanitation and Health{"} - 1998 : Resolving conflicts between Drinking-Water Demands and Pressures from Society´s Wastes ; Conference date: 24-11-1998 Through 28-11-1998",

url = "http://www.gbv.de/dms/ilmenau/toc/313604576.PDF",

}

RIS

TY - CHAP

T1 - Drugs, Diagnostic Agents and Disinfectants in Wastewater and Water - A Review

AU - Kümmerer, Klaus

PY - 2000

Y1 - 2000

N2 - After administration pharmaceuticals are excreted by the patients into the aquatic environment via wastewater. Unused medications are sometimes disposed of in drains. The drugs may enter the aquatic environment and eventually reach drinking water, if they are not biodegraded or eliminated during sewage treatment. Additionally, antibiotics and disinfectants are assumed to disturb the wastewater treatment process and the microbial ecology in surface waters. Furthermore, resistant bacteria may be selected in the aeration tanks of sewage treatment plants by the antibiotic substances present. Since the 1980s, data on the occurrence of pharmaceuticals in natural surface waters and the effluents of sewage treatment plants have been reported. More recently, pharmaceuticals have been detected in ground and drinking water. However, only little is known about the risk imposed on humans by pharmaceuticals and their metabolites in surface and drinking water. An overview of input, occurrence, elimination (e.g. biodegradability) and possible effects of different pharmaceutical groups such as anti-tumour drugs, antibiotics and contrast media as well as AOX resulting from hospitals effluent input into sewage water and surface water is presented

AB - After administration pharmaceuticals are excreted by the patients into the aquatic environment via wastewater. Unused medications are sometimes disposed of in drains. The drugs may enter the aquatic environment and eventually reach drinking water, if they are not biodegraded or eliminated during sewage treatment. Additionally, antibiotics and disinfectants are assumed to disturb the wastewater treatment process and the microbial ecology in surface waters. Furthermore, resistant bacteria may be selected in the aeration tanks of sewage treatment plants by the antibiotic substances present. Since the 1980s, data on the occurrence of pharmaceuticals in natural surface waters and the effluents of sewage treatment plants have been reported. More recently, pharmaceuticals have been detected in ground and drinking water. However, only little is known about the risk imposed on humans by pharmaceuticals and their metabolites in surface and drinking water. An overview of input, occurrence, elimination (e.g. biodegradability) and possible effects of different pharmaceutical groups such as anti-tumour drugs, antibiotics and contrast media as well as AOX resulting from hospitals effluent input into sewage water and surface water is presented

KW - Aeration

KW - AGENTS

KW - ANTIBIOTIC

KW - Antibiotics

KW - AOX

KW - aquatic

KW - aquatic environment

KW - bacteria

KW - BACTERIUM

KW - biodegradability

KW - contrast media

KW - CONTRAST-MEDIA

KW - diagnostic agent

KW - disinfectant

KW - disinfectants

KW - drinking water

KW - DRINKING-WATER

KW - drug

KW - DRUGS

KW - ECOLOGY

KW - effect

KW - effects

KW - effluent

KW - EFFLUENTS

KW - elimination

KW - ENVIRONMENT

KW - HEALTH

KW - hospital

KW - HOSPITALS

KW - Human

KW - HUMANS

KW - MEDIA

KW - Metabolite

KW - METABOLITES

KW - occurrence

KW - PATIENT

KW - pharmaceutical

KW - pharmaceuticals

KW - PLANT

KW - PLANTS

KW - REACh

KW - RESISTANT BACTERIA

KW - RESISTANT-BACTERIA

KW - Review

KW - risk

KW - sewage

KW - sewage treatment

KW - sewage treatment plant

KW - sewage treatment plants

KW - SEWAGE WATER

KW - SEWAGE-TREATMENT

KW - SUBSTANCES

KW - SURFACE

KW - surface water

KW - SURFACE WATERS

KW - SURFACE-WATER

KW - treatment

KW - TREATMENT PLANTS

KW - TREATMENT-PLANT

KW - Waste

KW - waste water

KW - WASTE-WATER

KW - wastewater

KW - wastewater treatment

KW - WATER

KW - WATERS

KW - WELL

KW - Chemistry

UR - http://www.scopus.com/inward/record.url?scp=0033650179&partnerID=8YFLogxK

M3 - Article in conference proceedings

SN - 3-932816-34-X

SN - 978-3932816345

VL - 105

T3 - Schriftenreihe des Vereins für Wasser-, Boden- und Lufthygiene

SP - 59

EP - 71

BT - Water Sanitation and Health (WHO Water Series)

A2 - Chorus, Ingrid

A2 - Ringelband, U.

A2 - Schlag, G.

A2 - Schmoll, O.

PB - IWA Publishing

T2 - International Conference on the Subject of "Water, Sanitation and Health" - 1998

Y2 - 24 November 1998 through 28 November 1998

ER -

Correction to: Determination and risk assessment of UV filters and benzotriazole UV stabilizers in wastewater from a wastewater treatment plant in Lüneburg, Germany (Environmental Monitoring and Assessment, (2024), 196, 8, (725), 10.1007/s10661-024-12853-2)

Ajibola, A. S., Reich, M. & Kümmerer, K., 11.2024, in: Environmental Monitoring and Assessment. 196, 11, 1 S., 1095.

Publikation: Beiträge in Zeitschriften › Kommentare / Debatten / Berichte › Forschung

Designing greener active pharmaceutical ingredients: Insights from pharmaceutical industry into drug discovery and development

Puhlmann, N., Vidaurre, R. & Kümmerer, K., 01.01.2024, in: European Journal of Pharmaceutical Sciences. 192, 13 S., 106614.

Publikation: Beiträge in Zeitschriften › Zeitschriftenaufsätze › Forschung › begutachtet